GHP Healthcare & Pharmaceutical Awards 2020 (Packages)

Page 1

Healthcare Healthcare & Pharmaceutical & Pharmaceutical Awards 2019 Awards 2020

The Packages


The Primary Package • Full page of editorial – approx. 900 words • 1 crystal trophy • Personalised digital Logo

Company Name

Healthcare and Full page of editorial

Pharmaceuitcal 

Awards 2020 Award Title

Best R&D Services Laboratory - Pennsylvania

Personalised digital logo

Headquartered in a 5,000 GSF chemistry R&D and kilo-capacity scale-up (up to 100 liter) lab in Levittown, PA, with oversea R&D and pilot plant (up to 5000 liter) subsidiaries, Aris design of hit compounds, focused library synthesis to process development and scaling up. We profile the firm to learn more about how its work came to be recognised in this year’s Healthcare Founded in 2011, Aris Pharmaceuticals is a dynamic chemistry service organization that serves and supports the R&D needs of over 100 pharmaceutical, biotechnology firms and institutes worldwide. Working with a wide range of clients, Aris Pharmaceuticals’ products and services parallel the new product discovery process and provide significant advantages with proven track record in quality-cost-value, at each step from computer aided core-structure design, hit-to-lead discovery and optimization, to scale-up preparation of intermediates and chemical process validation.

As part of this service offering, the firm perform laboratory scale synthesis for pharmaceutical companies, drug discovery and “virtual” companies, biotechnology companies, and academic institutions.

of dependability, and a fully equipped laboratory. As such, they are able to ensure that all of their clients’ projects are delivered on time, cost-effectively and with a high degree of quality.

Specifically, Aris Pharmaceuticals has majorly devoted in novel anti-viral AND immuno-oncology drug research programs, including the first in class small molecular HIV long term inhibitors, small molecule NK system activators and A2A adenosine receptor antagonists.

Looking to the future, Aris Pharmaceuticals will continue to strive towards innovation in the R&D market to drive real growth and expansion throughout the healthcare and pharmaceuticals space.

All these researches are conducted by the firm’s expert team of 140 professionals, who have solid experience, a high degree

GHP

Company: Aris Pharmaceuticals Inc Contact: Jason Yue, PhD, Site Manager Website: http://www.arispharma.com/ Email: info@arispharma.com; sales@arispharma.com

53

1 crystal trophy


The Secondary Package • Front cover logo – your company logo on the front cover of the Healthcare & Pharmaceutical Awards 2020 magazine • Full page of editorial – approx. 900 words • 2 crystal trophies • Personalised digital logo • Bespoke digital certificate

Front Cover Logo

Healthcare & Pharmaceutical Awards 2020

Personalised digital logo

CERTIFICATE This is to certify that:

Company Name/Logo Have Been Named:

Company Name

Healthcare and

Award Title

DATE

Pharmaceuitcal Awards 2020 Award Title

Digital certificate 

Plate System: Combat Anterior Cervical Plate System

we profile it to find out more. Thanks to several years of input, design and development from leaders in the medical and engineering industries ISPINE has now created industry leading products offering surgeons the best possible package for their patients. These unique products greatly assist surgeons from all over the world in their quest to improve the quality of life of their patients while keeping in mind the rising costs of medical technology. From the beginning, ISPINE has been focused on developing products that deliver cost effective, faster and more efficient patient care. With industry leaders in the medical and engineering fields advancing the ISPINE range the firm has come to pride itself on delivering excellent value to clients.

Over the years, the firm has become an industry leader committed to providing only the highest possible quality solutions to healthcare providers from across the market and around the world. Based in South Africa, the firm can provide fully-compliant solutions that are designed to be of the highest possible quality and as innovative as possible. Among the firm’s portfolio of products is its award-winning Combat Anterior Cervical Plate System, which gives surgeons the flexibility to easily customize them to each patient’s unique anatomy. Flexibility is built-in to every aspect of the systems; from plate design and the innovative Single-Twist anti-migration system to the screw options and the instrumentation set. The result is a cervical plate system that is effective and easy to use. This creative solution boasts multiple constructs for optimum flexibility and performance. The color-coded fixed and variable angle screws can be used alone or in combination to meet anatomical variations and achieve the surgeon’s desired goal. Ultimately, ISPINE is on a mission to provide industry leading products and service whilst at the same time not losing sight of rising costs to ensure that healthcare providers receive quality solutions and value for money.

ispine.co.za

Wayne Roach - ISPINE

Contact Details: Company: ISPINE Contact: Wayne Roach Website: ispine.co.za Email: wayne.roach@ispine.co.za / belinda.malan@ispine.co.za

38 GHP

Full page of editorial

2 crystal trophies


The Tertiary Package • Supporting cover image and headline • Two pages of editorial at the front end of the magazine approx. 1,800 words • 2 crystal trophies • 1 glass plaque • 4-page e-magazine dedicated solely to you/your company • 20 printed copies of your personalised e-magazine • Personalised digital logo • Bespoke digital certificate

Healthcare & Pharmaceutical Awards 2020

CERTIFICATE This is to certify that:

Company Name/Logo Have Been Named:

Award Title

DATE

Supporting cover image and headline

Digital certificate 

an immune response, delivering long-term protection alongside that of immediate protection. Throughout the last four years, Medi-Immune has developed prototypes into lightweight, battery-powered, wearable examples. In vitro performance testing, carried out at Public Health England in Porton Down, confirmed performance which matched with predicted results, and the company were able to move on to in vivo trials.

Company 2019 - Europe A small, UK-based research and development company, Medi-Immune Ltd. is at the

Founded in 2008, immunology company Medi-Immune is responsible for developing new and innovative technology that seeks to address the everimpending threat of new pathogens. Aiming to deliver protection from airborne pathogens regardless of mutation, Medi-Immune are offering a unique solution to a dangerous possibility.

Scientists across the world and the World Health Organisation have predicted that society can expect another airborne pandemic, despite not knowing where it will originate from, or when. Current scientific knowledge estimates it will emerge from a mutation of avian influenza, with likely mutations being one or two steps away from human infection and transmission. When the pathogen does arrive, there will be an immediate need to identify the disease, before developing and producing a vaccine in suitable numbers. Respiratory diseases can be extremely costly to deal with, including high mortality rates, such as the 2009 swine flu epidemic which ended up costing the UK more than one billion pounds, purely in preparatory and response costs. Adding hospitalisation and loss-of-income costs pushed the figure much higher. Providing immediate protection solutions against all airborne pathogens to save lives and money is the primary goal of Medi-Immune, a small UK-based research and development company specialising in immunisation and pathogens. Whilst respiratory protection has remained unchanged for a number of years, this company has developed ground-breaking technology, ProtectivAir®.

34 GHP

The in vivo trials were designed to demonstrate the device’s ability to deliver superior protection from airborne pathogens against existing filtered systems. These trials also confirmed that an immune response was initiated. The use of the device prevents infection from known pathogens and will prove uniquely effective in an environment with an infectious level of currently unknown pathogens.

Medi-Immune Ltd.

These test results represent a massive and radical shift in the field immunology and protection from as-yet unknown airborne pathogens. Medi-Immune and ProtectivAir® promise to be useful tools in supplementing and complementing existing vaccine developments for years to come, especially with the potential development of a new airborne pathogen. In addition to the instant protection that the device offers against new mutations, the underlying technology can also be utilised in existing stable environments. Where patients with compromised immune systems require protection, ProtectivAir® will also prove an invaluable and important tool. Recently, there has been exciting development, testing and modelling to allow ProtectivAir® to be installed and used within a cabin environment during transportation, initially in automobiles, to enhance

existing air handling systems to protect and help prevent transmission of airborne infections amongst those travelling. Future development could help protect against diseases that can travel internationally aboard aircraft, Medi-Immune is always developing the potential for this groundbreaking new technology Ultimately, what makes Medi-Immune a success is their unwavering ability to create new and innovative technology that can protect everyone from an unseen threat. By creating wearable technology that offers both immediate and long-term protection against new and old airborne pathogens alike, this company are changing the way science looks at immunisation and viral protection for good. Company: Medi-Immune Ltd. Contact: John Willcocks Email: johnwillcocks@medi-immune.com Website: www.medi-immune.com

ProtectivAir® is a new and improved approach that provides non-infective air that can be delivered via a personal wearable device or integrated into existing close environments to protect multiple people. Developed by three of Medi-Immune’s inventive directors, James Love, John Maudsley, and John James, this new protective device is representing a clear shift in the existing field of immunology and pathogen protection. With technology at the forefront of the immunology industry, Medi-Immune have created the device to eliminate the threat of any airborne pathogens. ProtectivAir® uses ultraviolet C, shortwave germicidal radiation, to sterilise any inhaled airborne pathogens. The air passes through a compact, wearable sterilising chamber where the UVc photons pass through the pathogens and disable their ability to reproduce. Used with a filter-free face mask, a ten-billion times reduction in viable influenza viral particles is achieved at normal breathing rates. Because the method does not use a filtration system, it allows disabled airborne pathogens to be delivered directly to the respiratory tract of the wearer. Then, the disabled pathogens allow the body to initiate

GHP

35

Two pages of editorial Glass Plaque

Company Name

Healthcare and Pharmaceuitcal Awards 2020 Award Title

Personalised digital logo

2 Crystal Trophies


Editor’s Choice Package • Main front cover image and headline on the celebratory magazine • Four pages of editorial at the front end of the magazine – approx. 3,000 words • 3 crystal trophies • 1 glass plaque • 8-page e-magazine dedicated solely to you/your company • 50 printed copies of your personalised e-magazine • 1 dedicated page in every quarterly issue of GHP throughout 2020 • Personalised digital logo • Bespoke digital certificate

Healthcare & Pharmaceutical Awards 2020

CERTIFICATE This is to certify that:

Company Name/Logo Have Been Named:

Award Title

DATE

Main front cover image and headline

Digital certificate 

FarmaForce

FarmaForce

FarmaForce: Best Health & Pharma - Australia (CSO) renowned for providing high performing sales

FarmaForce was established in 2014 with a clear purpose – to provide an unprecedented level of sales force excellence through strategic partnerships with pharmaceutical companies in the ever-changing healthcare industry.

“Based on experience and research, we knew that the healthcare CSO market is littered with transactional engagements that short-changed the customers’ best interest and those of the healthcare space itself,” said

Ghay Haidar, Sales Director of FarmaForce. “We saw this as an opportunity to focus on establishing a mindset of building long-term, rewarding partnerships founded on shared success.”

“...We saw this as an opportunity to focus on establishing a mindset of building long-term, rewarding partnerships founded on shared success.”

Ghay is part of a leadership team that boasts more than 100 years’ collective experience in building successful sales teams and delivering results for clients, a key factor in FarmaForce’s growth to become Australia’s premier healthcare CSO. Over the past 12 months, the company has built and launched

Company: FarmaForce Address: Level 9, 85 Castlereagh Street, Sydney NSW 2000, Australia Telephone Number: +61 2 8239 5400 Web Address: farmaforce.com.au

GHP

6 GHP

9

GHP

7

Four pages of editorial Glass Plaque

Company Name

Healthcare and Pharmaceuitcal Awards 2020 Award Title

Personalised digital logo

3 Crystal Trophies


Individual Items: Crystal trophy Glass plaque Personalised digital logo Bespoke digital certificate Full page of editorial

Full page of editorial

Bespoke digital certificate

 Dennison Psychology

Dennison Psychology: Most Trusted Private Psychology provides this vital support to clients in Melbourne. Established with one psychologist working on a part-time basis out of a single consulting room, over the past six years Dennison Psychology has experienced dramatic organic growth to a team of seven psychologists, operating within independent purpose-built premises. Today the practice’s team of highly-qualified psychologists (the majority of whom have completed post-registration endorsement programs, which recognise higher-level training/ abilities) offer services to adults,

adolescents, children and couples. Treatment is provided for a wide range of issues, across the spectrum of severity: from clients who wish to improve their relationship or better manage stress, to clients suffering from severe and complex psychiatric disorders. In terms of service offerings, the practice ensures its team of psychologists are trained in a diverse range of evidence-based treatment approaches, and have an interest in working with particular client populations and their presenting issues. This means individuals who attend Dennison Psychology can be matched to the psychologist(s) who

are best suited to their specific treatment needs. To this effect, the practice provides a free customised matching service to potential new clients. The decision to offer this service was driven by the research in the field, which demonstrates that client treatment gains tend to be greatly affected by the fit between a client and their treating psychologist. Dennison Psychology’s focus on skill enhancement comes from the top. For the past six years, the practice’s founder and principle psychologist Dr Joanne Dennison has sat on the national executive board of the Australian Psychological Society’s Counselling College and, during this time, has served as Chair of the board’s state committee in Victoria. Through forecasting emerging market developments, the practice strives to anticipate industry changes and adapt accordingly. The practice assumes that, in the near future, the Australian government will implement the recommendations recently made by the Australian Psychological Society (APS) in their White Paper submission. This will have a knock-on impact on the field of psychology at large. At a private practice level, it is likely to improve how financially accessible treatment is for clients of private psychology practices in Australia. With this in mind, Dennison Psychology is currently in the process of planning changes it will make, should policy changes ensue.

Digital certificate

Looking ahead, Dennison Psychology intends to continue utilising a sustainable growth model, that remains adaptive to industry changes, whilst maintaining a culture that fosters respect, quality and authenticity. Company: Dennison Psychology Name: Dr Joanne Dennison Address: Suite 3, 2 Avoca Street, South Yarra VIC 3141 Telephone Number: 03 9041 8351 Web: www.DennisonPsychology.com.au

GHP

Healthcare & Pharmaceutical Awards 2020 83

CERTIFICATE

Personalised digital logo

This is to certify that:

Company Name/Logo Company Name Have Been Named:

Healthcare and

Award Title

Pharmaceuitcal

DATE

Awards 2020 Award Title

Crystal trophy


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.